Angioplasty Balloons Market Report

Angioplasty Balloons Market Analysis By Type (Normal Balloons, Drug Eluting Balloons, Cutting Balloons, Scoring Balloons), By Application (Peripheral Vascular Disease, Coronary Artery Disease), By End Use, By Region, And Segment Forecasts, 2018 - 2024

  • Published Date: Jan, 2017
  • Base Year for Estimate: 2015
  • Report ID: GVR-1-68038-356-0
  • Format: Electronic (PDF)
  • Historical Data: 2013 - 2015
  • Number of Pages: 100

Industry Insights

The global angioplasty balloons market size was valued at USD 2.2 billion in 2015 and is projected to grow at a CAGR of 3.2% over the forecast period. This high growth is attributed to rising angioplasty procedures due to minimally invasive nature of the surgery.

Peripheral and coronary artery diseases are common signs of atherosclerosis and may lead to stroke, myocardial infarction, and/or cardiovascular death. Increasing incidence of these diseases is likely to boost the market in coming years.

U.S. angioplasty balloons market by type, 2013 - 2024 (USD Million)

U.S. angioplasty balloons market

Development in the imaging technologies and increasing patient population are expected to drive the market. Furthermore, continuous launch of efficient products also helps to boost the angioplasty balloons segment during the forecast period.

Rapid adoption of the advanced technologies in the angioplasty, such as drug-eluting and cutting balloons, is a major factor anticipated to propel the market. A key reason for high adoption is lower failure rate compared to traditional angioplasty techniques.

Type Insights

Normal balloons dominated the market in 2015 due to low cost of the devices, low government regulations & submissions for approval, favorable reimbursement policies, and availability of more products in the market.

For instance, in 2010 the U.S. FDA downgraded standard for normal balloon angioplasty catheters from class III medical devices to class II medical devices with special controls. This is anticipated to propel the segment, as the time for approval will decrease.

Drug-eluting balloons is anticipated to be fastest growing segment during the forecast period due to continuous approval of new products, advantages over standard balloon, and low cost as compared to stents.

Furthermore, adoption of specialty products, such as scoring and cutting balloons, and investment by market players in R & D are likely to drive the demand during the forecast period from 2016 to 2024. Specialty balloons such as AngioSculpt and Flextome received marketing authorization from the U.S., Europe, Japan, and other major markets’ regulatory agencies. Hence, availability of products in key markets is projected to increase their share during the forecast period.

Application Insights

Angioplasty balloons are segmented into coronary and peripheral by application. In 2015, coronary dominated the application segment due to high incidence of coronary artery diseases. Coronary heart disease is the most common type of all the heart diseases and it kills over 370,000 people annually in the U.S., as stated by the CDC.

Peripheral balloons segment is anticipated to be the most lucrative during the forecast period due to the approval of number of balloons in recent years, rising awareness about diseases related to peripheral arteries, and presence of peripheral angioplasty balloons in the pipeline.

For instance, in October 2014, the U.S. FDA approved Lutonix 035 manufactured by Lutonix, Inc. This was the first drug-coated balloon to treat blockage of superficial femoral and popliteal arteries.

End-Use Insights

Ambulatory surgery centers accounted for the largest share in 2015 due to huge demand for the treatment. This can be attributed to availability of advanced services, minimum hospital stay, and lower medical expenses.

Angioplasty balloon market, by end use, 2015

Angioplasty balloons market


Furthermore, private and public hospitals along with the Catheterization Laboratories (Cath Lab) are significantly contributing to the industry. Hospitals accounted second highest share of the market in 2015.


Regional Insights

In 2015, North America accounted for the maximum revenue share. The local presence of key industry players, the change in U.S. FDA policy, and growing number of percutaneous coronary interventions are the primary drivers of the region. 

Asia Pacific is expected to be the most lucrative region during the forecast period because of growing healthcare expenditure, rising government support, and investments by the market players in the region.

Competitive Insights

Some of the key players in the industry include Boston Scientific Corporation; Medtronic; Spectranetics; C. R. Bard, Inc.; Abbott; Cook Medical; Cardinal Health (Cordis); ENDOCOR GmbH; and Johnson & Johnson.

Partnerships or collaborations with well-established players and development of innovative & effective products are the major strategies deployed by players to increase the market share during the forecast period. For instance, in February 2015, Boston Scientific Corporation signed an agreement with C. R. Bard, Inc. for distribution of Lutonix drug-coated balloon in the U.S. This agreement would help Boston Scientific Corporation expand reach of the device and, thereby, help gain higher share in industry.

Report Scope



Base year for estimation


Actual estimates/Historical data

2013 - 2015

Forecast period

2016 - 2024

Market representation

Revenue in USD Million & CAGR from 2016 to 2024

Regional scope

North America, Europe, Asia Pacific, Latin America, & MEA

Country scope

U.S., Canada, UK, Germany, Japan, China, Brazil, Mexico, & South Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, & trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2013 to 2024. For the purpose of this study, Grand View Research has segmented the angioplasty balloon market on the basis of type, application, end-use, and region:

  • Type Outlook (Revenue, USD Million; 2013 - 2024)

    • Normal Balloons

    • Drug Eluting Balloons

    • Cutting Balloons

    • Scoring Balloons

  • Application Outlook (Revenue, USD Million; 2013 - 2024)

    • Coronary

    • Peripheral

  • End Use Outlook (Revenue, USD Million; 2013 - 2024)

    • ASCs

    • Hospitals

    • Cath Labs

  • Regional Outlook (Revenue, USD Million; 2013 - 2024)

    • North America

      • U.S.

      • Canada

    • Europe

      • UK

      • Germany

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,450
Multi User (2-5) - $6,450
Compass Access - $9,450

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified